0001181431-13-007792.txt : 20130207
0001181431-13-007792.hdr.sgml : 20130207
20130207192846
ACCESSION NUMBER: 0001181431-13-007792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130205
FILED AS OF DATE: 20130207
DATE AS OF CHANGE: 20130207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwabe Stefan K.F.
CENTRAL INDEX KEY: 0001557657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 13584294
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 1550 EAST GUDE DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
rrd368996.xml
X0306
4
2013-02-05
0
0001356576
SUPERNUS PHARMACEUTICALS INC
SUPN
0001557657
Schwabe Stefan K.F.
C/O SUPERNUS PHARMACEUTICALS, INC.
1550 EAST GUDE DRIVE
ROCKVILLE
MD
20850
0
1
0
0
Executive Vice President R&D
Common Stock
2051
D
Employee Stock Option (Right to Buy)
7.90
2013-02-05
4
A
0
20000
0
A
2023-02-05
Common Stock
20000
20000
D
The option vests in four equal annual installments beginning on February 5, 2014.
Includes 2,051 shares acquired under the Supernus stock purchase plan on December 31, 2012.
/s/ Gregory S. Patrick, as attorney-in-fact
2013-02-07